These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2895780)

  • 1. Selective dopamine-1 agonist therapy in severe hypertension: effects of intravenous fenoldopam.
    White WB; Radford MJ; Gonzalez FM; Weed SG; McCabe EJ; Katz AM
    J Am Coll Cardiol; 1988 May; 11(5):1118-23. PubMed ID: 2895780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
    Taylor AA; Shepherd AM; Polvino W; Mangoo-Karim R; Ballard K; Sunthornyothin S; Luther RR; Pool JL
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):906-14. PubMed ID: 10509549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular and renal profile of acute peripheral dopamine1-receptor agonism with fenoldopam.
    Glück Z; Jossen L; Weidmann P; Gnädinger MP; Peheim E
    Hypertension; 1987 Jul; 10(1):43-54. PubMed ID: 2885268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fenoldopam, a specific dopamine receptor agonist, on blood pressure and left ventricular function in systemic hypertension.
    Caruana MP; Heber M; Brigden G; Raftery EB
    Br J Clin Pharmacol; 1987 Dec; 24(6):721-7. PubMed ID: 2894216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of renal blood flow and sodium excretion in hypertensive patients during blood pressure reduction by intravenous administration of the dopamine1 agonist fenoldopam.
    Murphy MB; McCoy CE; Weber RR; Frederickson ED; Douglas FL; Goldberg LI
    Circulation; 1987 Dec; 76(6):1312-8. PubMed ID: 2890447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension.
    Hackman BB; Griffin B; Mills M; Ramanathan KB
    Am J Cardiol; 1992 Apr; 69(9):918-22. PubMed ID: 1347965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of intravenous administration of fenoldopam on blood pressure and renal function in severe arterial hypertension].
    Miranda B; Ruilope LM; García Robles R; Alcázar JM; Sancho J; Tover J; Martínez A; Astorga M; Rodicio JL
    Med Clin (Barc); 1988 Oct; 91(12):445-8. PubMed ID: 2905401
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension.
    Bednarczyk EM; White WB; Munger MA; Gonzalez FM; Panacek EA; Weed SG; Rutherford WF; Nara AR; Green JA
    Am J Cardiol; 1989 Apr; 63(13):993-6. PubMed ID: 2564726
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure.
    Francis GS; Wilson BC; Rector TS
    Am Heart J; 1988 Aug; 116(2 Pt 1):473-9. PubMed ID: 2899970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies with fenoldopam, a dopamine receptor DA1 agonist, in essential hypertension.
    Harvey JN; Worth DP; Brown J; Lee MR
    Br J Clin Pharmacol; 1986 Jan; 21(1):53-61. PubMed ID: 2868748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenoldopam infusion for the treatment of postoperative hypertension.
    Goldberg ME; Cantillo J; Nemiroff MS; Subramoni J; Muñoz R; Torjman M; Schieren H
    J Clin Anesth; 1993; 5(5):386-91. PubMed ID: 8105829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertension.
    Munger MA; Rutherford WF; Anderson L; Hakki AI; Gonzalez FM; Bednarczyk EM; Emmanuel G; Weed SG; Panacek EA; Green JA
    Crit Care Med; 1990 May; 18(5):502-4. PubMed ID: 1970283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension.
    White WB; Halley SE
    Arch Intern Med; 1989 Apr; 149(4):870-4. PubMed ID: 2565105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic properties of intravenous fenoldopam, a dopamine1-receptor agonist, in hypertensive patients.
    Weber RR; McCoy CE; Ziemniak JA; Frederickson ED; Goldberg LI; Murphy MB
    Br J Clin Pharmacol; 1988 Jan; 25(1):17-21. PubMed ID: 2897206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal effects of fenoldopam in refractory hypertension.
    Ruilope LM; Robles RG; Miranda B; Tovar J; Alcazar JM; Sancho J; Rodicio JL; Martinez A; Astorga A; Beck T
    J Hypertens; 1988 Aug; 6(8):665-9. PubMed ID: 2903190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective peripheral dopamine-1 receptor stimulation with fenoldopam in human essential hypertension.
    Carey RM; Stote RM; Dubb JW; Townsend LH; Rose CE; Kaiser DL
    J Clin Invest; 1984 Dec; 74(6):2198-207. PubMed ID: 6150942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure increases with fenoldopam, but not nitroprusside, in hypertensive humans.
    Elliott WJ; Karnezis TA; Silverman RA; Geanon J; Tripathi RC; Murphy MB
    Clin Pharmacol Ther; 1991 Mar; 49(3):285-93. PubMed ID: 1672512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.
    Reisin E; Huth MM; Nguyen BP; Weed SG; Gonzalez FM
    Hypertension; 1990 Feb; 15(2 Suppl):I59-62. PubMed ID: 1967592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.